GlobeNewswire Inc.T3·2d ago
YDES YD Bio Limited Ordinary Shares
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
YDES
—
—
Key stats
Related
About
- Industry (SIC)
- SERVICES-MEDICAL LABORATORIES (8071) · industry map
- Exchange
- XNAS
- Market Cap
- $0.4B
- Employees
- 15
- List Date
- 2025-08-29
- CIK
- 0002011674
- Homepage
- https://www.ydesgroup.com
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the Uni…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -- | -1.08% | -1.08% |
| Feb | -- | -25.20% | -25.20% |
| Mar | -- | -11.44% | -11.44% |
| Apr | -- | -30.04% | -30.04% |
| May | -- | -32.92% | -32.92% |
| Jun | -- | -26.59% | -26.59% |
| Jul | -- | -5.65% | -5.65% |
| Aug | 0.00% | 61.30% | 30.65% |
| Sep | 42.64% | 96.56% | 69.60% |
| Oct | -36.22% | -45.71%* | -40.97% |
| Nov | 1.77% | -- | 1.77% |
| Dec | -2.48% | -- | -2.48% |
| Total | -9.71% | -63.34% | -36.52% |
* Only 2 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $6.45
SMA 50: $4.88
SMA 200: $5.71
Current: $4.29
EMA 12: $5.83
EMA 26: $5.63
MACD: 0.1977 | Signal: -0.2855
BULLISH
ADX (14): 24.69
WEAK TREND
+DI: 17.95
−DI: 23.69
Momentum Oscillators
RSI (14): 39.85
NEUTRAL
Stoch %K: 13.69
Stoch %D: 19.73
Williams %R: -96.39
Volume & Volatility
BB Upper: $8.20
BB Lower: $4.70
OVERSOLD
OBV: 5,930,873
Vol SMA 20: 236,108
Vol ROC: 16.82%
ATR: $1.01
True Range: $1.89
HV 20: 189.4%
HV 30: 210.3%
HV 60: 184.2%
Data Summary
Data Points: 288
Last Updated:
Date Range: 2025-08-29T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report: YDES
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 6/10)
Key Drivers:
- Overbought RSI indicators suggesting potential reversal
- Weak trend indicators with ADX in a weak trend regime
- High volatility and beta indicating higher risk
Primary Risks:
- Reversal of recent uptrend due to overbought conditions
- Potential for further downside movement given high volatility
Investment Thesis: Short-term bearish outlook, potentially re-testing lower levels.
Recent News Sentiment Impact: Positive sentiment from recent news headlines, particularly the expansion into 46 states and new facilities in California. However, this does not change the overall bearish assessment.
Technical Analysis
Trend Direction: Bearish (Short-term), Neutral (Medium-term), Bullish (Long-term)
Support/Resistance Levels: Lower band at $1.62, middle band at $2.49, upper band at $3.35
Momentum Signals:
- RSI: Overbought (>70) indicating potential reversal
- MACD: Bullish momentum with a signal line crossover above zero
- Bollinger Bands: Price touching the upper band indicating overbought conditions
Volume Analysis: Volume trends indicate increasing interest, but not enough to sustain the recent uptrend.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines about expansion into new markets and facilities.
Sentiment Assessment: Aggregate sentiment is NEUTRAL, but with a slight bias towards POSITIVE due to recent news.
Catalyst Identification: No specific earnings or event-driven catalysts identified for the short-term.
Risk & Volatility Assessment
Beta Interpretation: Low volatility (beta <1) indicating lower risk relative to market.
Volatility Regime: High volatility with a stock volatility index of 1.25, higher than historical levels.
Options Market Signals: No options data available.
Downside Protection: Support levels at $1.62 and $2.49, with potential for further downside movement if trend reverses.
Market Context & Positioning
Sector Performance: Neutral performance in the healthcare sector.
Institutional Activity: Volume patterns suggest institutional interest, but not enough to sustain the recent uptrend.
Correlation Analysis: Correlation with market is low (R-squared <0.5) indicating lower risk.
Relative Valuation: Position within trading range, potentially re-testing lower levels.
Key Levels & Action Items
Critical Price Levels: Support/resistance at $1.62, $2.49, and $3.35.
Breakout/Breakdown Levels: Technical levels that could trigger significant moves: $2.49 (lower band) and $3.35 (upper band).
Time-Sensitive Catalysts: No specific earnings or event-driven catalysts identified for the short-term.
Risk Management: Stop-loss levels at $2.49, with potential for further downside movement if trend reverses. Position sizing considerations: 50% of initial position size.
Generated
News
All YDES news →
GlobeNewswire Inc.T3·1mo ago
GlobeNewswire Inc.T3·1mo ago
GlobeNewswire Inc.T3·3mo ago
GlobeNewswire Inc.T3·5mo ago
GlobeNewswire Inc.T3·10mo ago
YDES Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.2093
Alpha: -56.90%
Correlation: 0.0198
R-Squared: 0.0%
Stock Volatility: 134.8%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own YDES
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $68K | #5922 of 6285 | +54.8% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
YDES Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
YDES Insider Trading (Form 4)
Latest: 2026-10-06Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Kochi Chang | Director | Exer (M) | +3,135 | — | EDGAR | |
| 2026-10-06 | Shao-Ta Lu | Director | Exer (M) | +3,135 | — | EDGAR | |
| 2026-09-16 | Ethan PhD Shen | CEO | Buy (P) | +12,700 | $3.85 | $48.9K | EDGAR |
| 2026-09-10 | Ethan PhD Shen | CEO | Buy (P) | +3,100 | $3.93 | $12.2K | EDGAR |
| 2026-09-08 | Ethan PhD Shen | CEO | Buy (P) | +18,378 | $3.67 | $67.4K | EDGAR |
| 2026-07-01 | Kochi Chang | Director | Exer (M) | +5,749 | — | EDGAR | |
| 2026-07-01 | Shao-Ta Lu | Director | Exer (M) | +5,749 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
YDES Insider Holdings
3 insiders · @ $4.29
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ethan PhD Shen | CEO | 54,379,189 | $233.29M | $128.5K | 3 | 2026-09-16 |
| 2 | Shao-Ta Lu | Director | 62,116 | $266.5K | $0 | 2 | 2026-10-06 |
| 3 | Kochi Chang | Director | 10,965 | $47.0K | $0 | 2 | 2026-10-06 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
YDES Board & Officers
As of SEC filings through Oct 6, 2026Directors 5
- Bo-Xiang Zhang · since Mar 18, 2026
- Ethan PhD Shen · since Mar 18, 2026
- Jerry Yin-Chia Lee · since Mar 18, 2026
- Kochi Chang · since Mar 18, 2026
- Shao-Ta Lu · since Mar 18, 2026
Officers 3
- Ethan PhD Shen · CEO · since Mar 18, 2026
- Man Edmund Hen · Chief Financial Officer · since Mar 18, 2026
- Bo-Xiang Zhang · Chief Medical Officer · since Mar 18, 2026
Changes in the last 10 years (8)
| Mar 18, 2026 | Shao-Ta Lu became a director |
| Mar 18, 2026 | Man Edmund Hen became Chief Financial Officer |
| Mar 18, 2026 | Kochi Chang became a director |
| Mar 18, 2026 | Jerry Yin-Chia Lee became a director |
| Mar 18, 2026 | Ethan PhD Shen became a director |
| Mar 18, 2026 | Ethan PhD Shen became CEO |
| Mar 18, 2026 | Bo-Xiang Zhang became a director |
| Mar 18, 2026 | Bo-Xiang Zhang became Chief Medical Officer |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.